140 related articles for article (PubMed ID: 6433676)
21. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
22. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
23. Antiinflammatory properties of the new antirheumatic agent 4-acetylaminophenylacetic acid.
Fujisawa H; Nishimura T; Inoue Y; Ogaya S; Shibata Y; Nakagawa Y; Sato S; Kimura K
Arzneimittelforschung; 1990 Jun; 40(6):693-7. PubMed ID: 2168705
[TBL] [Abstract][Full Text] [Related]
24. Antiinflammatory potency of dehydrocurdione, a zedoary-derived sesquiterpene.
Yoshioka T; Fujii E; Endo M; Wada K; Tokunaga Y; Shiba N; Hohsho H; Shibuya H; Muraki T
Inflamm Res; 1998 Dec; 47(12):476-81. PubMed ID: 9892041
[TBL] [Abstract][Full Text] [Related]
25. Anti-oxidant, anti-inflammatory, analgesic and antipyretic activities of grapevine leaf extract (Vitis vinifera) in mice and identification of its active constituents by LC-MS/MS analyses.
Aouey B; Samet AM; Fetoui H; Simmonds MSJ; Bouaziz M
Biomed Pharmacother; 2016 Dec; 84():1088-1098. PubMed ID: 27780137
[TBL] [Abstract][Full Text] [Related]
26. The comparative pharmacology of benoxaprofen.
Dawson W
J Rheumatol Suppl; 1980; 6():5-11. PubMed ID: 6771399
[TBL] [Abstract][Full Text] [Related]
27. [The antiinflammatory effect of EB-382].
Fujiyoshi T; Ikeda K; Saito M; Yamaura T; Iida H; Maeda E; Kase N; Uematsu T
Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):379-95. PubMed ID: 3087847
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
Matsushita M; Masaki M; Yagi Y; Tanaka T; Wakitani K
Inflamm Res; 1997 Nov; 46(11):461-6. PubMed ID: 9427067
[TBL] [Abstract][Full Text] [Related]
29. The pharmacologic effects of 5-[3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl]-1,3,4-thiadiazole-2(3H)-thione, choline salt (CI-986), a novel inhibitor of arachidonic acid metabolism in models of inflammation, analgesia and gastric irritation.
Schrier DJ; Baragi VM; Connor DT; Dyer RD; Jordan JH; Imre KM; Lesch ME; Mullican MD; Okonkwo GC; Conroy MC
Prostaglandins; 1994 Jan; 47(1):17-30. PubMed ID: 8140259
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.
DiMartino MJ; Griswold DE; Berkowitz BA; Poste G; Hanna N
Agents Actions; 1987 Feb; 20(1-2):113-23. PubMed ID: 3107354
[TBL] [Abstract][Full Text] [Related]
31. Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers.
Demerson CA; Humber LG; Abraham NA; Schilling G; Martel RR; Pace-Asciak C
J Med Chem; 1983 Dec; 26(12):1778-80. PubMed ID: 6227748
[TBL] [Abstract][Full Text] [Related]
32. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.
Futaki N; Yoshikawa K; Hamasaka Y; Arai I; Higuchi S; Iizuka H; Otomo S
Gen Pharmacol; 1993 Jan; 24(1):105-10. PubMed ID: 8482483
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis.
Neuman RG; Wilson BD; Barkley M; Kimball ES; Weichman BM; Wood DD
Agents Actions; 1987 Jun; 21(1-2):160-6. PubMed ID: 2957897
[TBL] [Abstract][Full Text] [Related]
34. Is licofelone, a dual inhibitor of cyclo-oxygenase and 5-lipoxygenase, a promising alternative in anti-inflammatory therapy?
Bannwarth B
Fundam Clin Pharmacol; 2004 Feb; 18(1):125-30. PubMed ID: 14748764
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological profiles of 2-carboxyphenyl-1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate and 2-[(2-carboxyphenoxy)-carbonyl]phenyl-1-(4-chlorobenzoyl)-5-meth oxy-2- methylindole-3-acetate, new antiinflammatory agents.
Tanaka I; Yoshizumi H; Tanaka Y; Takeda S; Kamei C; Nakaya N; Kitazumi K; Tagami H; Tasaka K
Arzneimittelforschung; 1986 Apr; 36(4):703-9. PubMed ID: 3487327
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
Grau M; Guasch J; Montero JL; Felipe A; Carrasco E; Juliá S
Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528
[TBL] [Abstract][Full Text] [Related]
37. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
Goto J; Muramatsu M; Hosoda K; Otomo S; Aihara H
Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
[TBL] [Abstract][Full Text] [Related]
38. Models for evaluating the anti-inflammatory effects of inhibitors of arachidonic acid metabolism.
Blackham A; Norris AA; Woods FA
J Pharm Pharmacol; 1985 Nov; 37(11):787-93. PubMed ID: 2867159
[TBL] [Abstract][Full Text] [Related]
39. Antiinflammatory agents and inhibition of ocular prostaglandin synthetase.
Ku EC; Signor C; Eakins E
Adv Prostaglandin Thromboxane Res; 1976; 2():819-23. PubMed ID: 824938
[No Abstract] [Full Text] [Related]
40. 4-Hydroxy-3-quinolinecarboxamides with antiarthritic and analgesic activities.
Clemence F; Le Martret O; Delevallee F; Benzoni J; Jouanen A; Jouquey S; Mouren M; Deraedt R
J Med Chem; 1988 Jul; 31(7):1453-62. PubMed ID: 3133478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
